...
首页> 外文期刊>European Journal of Nuclear Medicine and Molecular Imaging >Comparsson of methods for thyroid volume estimation in patients with Graves5 disease
【24h】

Comparsson of methods for thyroid volume estimation in patients with Graves5 disease

机译:Graves病患者甲状腺容量估算方法的比较

获取原文
获取原文并翻译 | 示例

摘要

Individualised dosage models are frequently applied for radioiodine therapy in patients with Graves' hyperthyroidism, especially in Europe. In these dosage schemes the thyroid volume is an important parameter. Thyroid volume determinations are usually made with ultrasonography or with thyroid scintigraphy, although the accuracy of planar scintigraphy for this purpose is not well established. The aim of this study was to compare the accuracy of three modalities for the determination of the thyroid volume in patients with Graves' disease: planar scintigraphy (PS), single-photon emission tomography (SPET) and ultrasonography (US). These three modalities were compared with magnetic resonance imaging (MRI) as the gold standard. Thyroid volume estimations were performed in 25 patients with Graves' disease. The PS images were subjected to filtering and thresholding, and a standard surface formula was used to calculate the thyroid volume. With SPET the it-eratively reconstructed thyroid images were filtered, and after applying a threshold method an automatic segmentation algorithm was used for the volume determinations. Thyroid volumes were estimated from the US images using the ellipsoid volume model for multiple two-dimensional measurements. For MRI, thyroid segmentation was performed manually in gadolinium-enhanced Tl-weighted images and a summation-of-areas technique was used for the volume measurements. The thyroid volumes calculated with MRI were 25.0+-13.8 ml (mean+-SD, range 7.0-56.3 ml). PS correlated poorly with MRI (R~2=0.61) and suffered from a considerable bias (-4.0+-17.6 ml). The differences between PS and MRI volume estimations had a very large spread (33+-58%). For SPET both the correlation with MRI (R2=0.84) and the bias (1.8+-11.9 ml) were better than for PS. US had by far the best correlation with MRI (R~2=0.91) and the best precision, but the bias (6.8+-7.5 ml) was not negligible. In conclusion, SPET is preferred over PS for accurate measurements of thyroid volume. US is the most accurate of the three modalities, if a correction is made for bias.
机译:个体化的剂量模型经常用于Graves甲状腺功能亢进症患者的放射碘治疗,尤其是在欧洲。在这些剂量方案中,甲状腺体积是重要的参数。甲状腺体积的测定通常通过超声检查或甲状腺闪烁显像确定,尽管为此目的平面闪烁显像的准确性尚不明确。这项研究的目的是比较三种方法确定Graves病患者甲状腺容量的准确性:平面闪烁显像(PS),单光子发射断层扫描(SPET)和超声检查(US)。将这三种模式与磁共振成像(MRI)作为金标准进行了比较。对25名Graves病患者进行了甲状腺体积估计。对PS图像进行滤波和阈值处理,并使用标准表面公式计算甲状腺体积。使用SPET对经过迭代重建的甲状腺图像进行过滤,并在应用阈值方法后,使用自动分割算法进行体积测定。使用椭圆体模型对多个二维测量结果从美国图像中估计甲状腺体积。对于MRI,在g增强的T1加权图像中手动进行甲状腺分割,并使用面积求和技术进行体积测量。 MRI计算的甲状腺体积为25.0 + -13.8 ml(平均值±SD,范围7.0-56.3 ml)。 PS与MRI的相关性较差(R〜2 = 0.61),并且偏倚较大(-4.0 + -17.6 ml)。 PS和MRI体积估计之间的差异非常大(33 + -58%)。对于SPET,与MRI的相关性(R2 = 0.84)和偏倚(1.8 + -11.9 ml)均优于PS。迄今为止,US与MRI的相关性最好(R〜2 = 0.91),并且精度最高,但偏差(6.8 + -7.5 ml)不可忽略。总之,对于甲状腺体积的准确测量,SPET比PS更可取。如果对偏差进行校正,则US是这三种方式中最准确的一种。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号